Relevant bibliographies by topics / Drugs Nanoparticles

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Drugs Nanoparticles'

Author: Grafiati
Published: 4 June 2021
Last updated: 11 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Drugs Nanoparticles.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Drugs Nanoparticles"

1

Wijaya, Christian J., Suryadi Ismadji, and Setiyo Gunawan. "A Review of Lignocellulosic-Derived Nanoparticles for Drug Delivery Applications: Lignin Nanoparticles, Xylan Nanoparticles, and Cellulose Nanocrystals." Molecules 26, no. 3 (2021): 676. http://dx.doi.org/10.3390/molecules26030676.

Full text
Abstract:
Due to their biocompatibility, biodegradability, and non-toxicity, lignocellulosic-derived nanoparticles are very potential materials for drug carriers in drug delivery applications. There are three main lignocellulosic-derived nanoparticles discussed in this review. First, lignin nanoparticles (LNPs) are an amphiphilic nanoparticle which has versatile interactions toward hydrophilic or hydrophobic drugs. The synthesis methods of LNPs play an important role in this amphiphilic characteristic. Second, xylan nanoparticles (XNPs) are a hemicellulose-derived nanoparticle, where additional pretreat
APA, Harvard, Vancouver, ISO, and other styles
2

Sizochenko, Natalia, and Jerzy Leszczynski. "Drug-Nanoparticle Composites." Journal of Nanotoxicology and Nanomedicine 2, no. 1 (2017): 1–10. http://dx.doi.org/10.4018/jnn.2017010101.

Full text
Abstract:
Polymeric nanoparticles represent attractive targets for the controlled delivery of therapeutic drugs. Drug-nanoparticle conjugates are convenient targets to enhance solubility and membrane permeability of drugs, prolong circulation time and minimize non-specific uptake. The behavior of drugs-loaded nanoparticles is governed by various factors. Understanding of these effects is very important for design of drug-nanoparticle systems, that could be suitable for treating the particular diseases. The aim of the current study is a complementary molecular docking followed by quantitative structure-a
APA, Harvard, Vancouver, ISO, and other styles
3

Rajeswari, R., and R. Jothilakshmi. "Magnetic Nanoparticles as Drug Carriers: Review." Materials Science Forum 807 (November 2014): 1–12. http://dx.doi.org/10.4028/www.scientific.net/msf.807.1.

Full text
Abstract:
Magnetic nanoparticles are made up of magnetic elements such as iron, nickel, cobalt and their oxides. Their unique physical and chemical properties, biocompatibility and their ability to be manipulated by external magnetic fields have made them as popular drug carriers in recent years. They offer various advantages such as ability to carry drugs to the desired areas in the body, and the ability to release the drugs in a controlled manner which in turn help in reducing side effects to other organs and in providing correct dosage of drugs. However, the complexity of the drug delivery system is
APA, Harvard, Vancouver, ISO, and other styles
4

Masri, Abdulkader, Ayaz Anwar, Dania Ahmed, Ruqaiyyah Siddiqui, Muhammad Raza Shah, and Naveed Khan. "Silver Nanoparticle Conjugation-Enhanced Antibacterial Efficacy of Clinically Approved Drugs Cephradine and Vildagliptin." Antibiotics 7, no. 4 (2018): 100. http://dx.doi.org/10.3390/antibiotics7040100.

Full text
Abstract:
This paper sets out to determine whether silver nanoparticles conjugation enhance the antibacterial efficacy of clinically approved drugs. Silver conjugated Cephradine and Vildagliptin were synthesized and thoroughly characterized by ultraviolet visible spectrophotometry (UV-vis), Fourier transform infrared (FT-IR) spectroscopic methods, atomic force microscopy (AFM), and dynamic light scattering (DLS) analysis. Using antibacterial assays, the effects of drugs alone and drugs-conjugated with silver nanoparticles were tested against a variety of Gram-negative and Gram-positive bacteria includin
APA, Harvard, Vancouver, ISO, and other styles
5

Chiellini, Elisabetta E., Federica Chiellini, and Roberto Solaro. "Bioerodible Polymeric Nanoparticles for Targeted Delivery of Proteic Drugs." Journal of Nanoscience and Nanotechnology 6, no. 9 (2006): 3040–47. http://dx.doi.org/10.1166/jnn.2006.412.

Full text
Abstract:
Significant efforts are being devoted to develop nanotechnology for drug delivery, mainly because of the distinct advantages offered by nanometer-size polymeric systems. Moreover, targeted drug delivery can be obtained by polymer conjugation to biospecific ligands. The present investigation was aimed mainly at determining the targeting ability of hybrid nanoparticles based on synthetic polymer/protein hybrid matrices. These nanoparticles were designed for liver targeted release of proteic drugs with antiviral activity, such as α-interferon. Human serum albumin and the monoesters of alternating
APA, Harvard, Vancouver, ISO, and other styles
6

Hong, Seyoung, Dong Wook Choi, Hong Nam Kim, Chun Gwon Park, Wonhwa Lee, and Hee Ho Park. "Protein-Based Nanoparticles as Drug Delivery Systems." Pharmaceutics 12, no. 7 (2020): 604. http://dx.doi.org/10.3390/pharmaceutics12070604.

Full text
Abstract:
Nanoparticles have been extensively used as carriers for the delivery of chemicals and biomolecular drugs, such as anticancer drugs and therapeutic proteins. Natural biomolecules, such as proteins, are an attractive alternative to synthetic polymers commonly used in nanoparticle formulation because of their safety. In general, protein nanoparticles offer many advantages, such as biocompatibility and biodegradability. Moreover, the preparation of protein nanoparticles and the corresponding encapsulation process involved mild conditions without the use of toxic chemicals or organic solvents. Pro
APA, Harvard, Vancouver, ISO, and other styles
7

Urista, Diana V., Diego B. Carrué, Iago Otero, et al. "Prediction of Antimalarial Drug-Decorated Nanoparticle Delivery Systems with Random Forest Models." Biology 9, no. 8 (2020): 198. http://dx.doi.org/10.3390/biology9080198.

Full text
Abstract:
Drug-decorated nanoparticles (DDNPs) have important medical applications. The current work combined Perturbation Theory with Machine Learning and Information Fusion (PTMLIF). Thus, PTMLIF models were proposed to predict the probability of nanoparticle–compound/drug complexes having antimalarial activity (against Plasmodium). The aim is to save experimental resources and time by using a virtual screening for DDNPs. The raw data was obtained by the fusion of experimental data for nanoparticles with compound chemical assays from the ChEMBL database. The inputs for the eight Machine Learning class
APA, Harvard, Vancouver, ISO, and other styles
8

Shaikh, Ahson Jabbar, Nargis Aman, and Muhammad Arfat Yameen. "A new methodology for simultaneous comparison and optimization between nanoparticles and their drug conjugates against various multidrug-resistant bacterial strains." Asian Biomedicine 13, no. 4 (2020): 149–62. http://dx.doi.org/10.1515/abm-2019-0054.

Full text
Abstract:
AbstractBackgroundMultidrug-resistant bacteria are becoming more hazardous day by day for human health all over the world, and the scientific community is trying hard to resolve this issue by various approaches. One of the very common approaches is to bind drugs to nanoparticles and study enhanced antibacterial properties.ObjectiveTo compare simultaneously different types of nanoparticles, their concentration, bacterial strains and their incubation time intervals for each of the selected drug combination.MethodsWe have selected the most commonly used gold and silver nanoparticles and few examp
APA, Harvard, Vancouver, ISO, and other styles
9

Katsikogianni, Georgia, and Konstantinos Avgoustakis. "Poly(lactide-co-glycolide)-Methoxy-Poly(ethylene glycol) Nanoparticles: Drug Loading and Release Properties." Journal of Nanoscience and Nanotechnology 6, no. 9 (2006): 3080–86. http://dx.doi.org/10.1166/jnn.2006.404.

Full text
Abstract:
In this work, the drug loading and in vitro release properties of PLGA-mPEG nanoparticles were studied. Three methyl-xanthine derivatives differing significantly in aqueous solubility, i.e., caffeine, theophylline, and theobromine, were employed as model drugs. Two different PLGA-mPEG copolymer compositions, namely PLGA(40)mPEG(5) and PLGA(136)mPEG(5), were included in the study. The nanoparticles were prepared by a double emulsion technique. The drug release properties of the nanoparticles in phosphate buffered saline (PBS) and in human plasma were determined. An increase of the drug proporti
APA, Harvard, Vancouver, ISO, and other styles
10

Lohcharoenkal, Warangkana, Liying Wang, Yi Charlie Chen, and Yon Rojanasakul. "Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy." BioMed Research International 2014 (2014): 1–12. http://dx.doi.org/10.1155/2014/180549.

Full text
Abstract:
Nanoparticles have increasingly been used for a variety of applications, most notably for the delivery of therapeutic and diagnostic agents. A large number of nanoparticle drug delivery systems have been developed for cancer treatment and various materials have been explored as drug delivery agents to improve the therapeutic efficacy and safety of anticancer drugs. Natural biomolecules such as proteins are an attractive alternative to synthetic polymers which are commonly used in drug formulations because of their safety. In general, protein nanoparticles offer a number of advantages including
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Drugs Nanoparticles"

1

Triplett, Michael David. "Enabling solid lipid nanoparticle drug delivery technology by investigating improved production techniques." Connect to this title online, 2004. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1101830018.

Full text
Abstract:
Thesis (Ph. D.)--Ohio State University, 2004.<br>Title from first page of PDF file. Document formatted into pages; contains xv, 172 p.; also includes graphics (some col.). Includes bibliographical references (p. 161-172).
APA, Harvard, Vancouver, ISO, and other styles
2

Zwiorek, Klaus. "Gelatin Nanoparticles as Delivery System for Nucleotide-Based Drugs." Diss., lmu, 2006. http://nbn-resolving.de/urn:nbn:de:bvb:19-63561.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Oliveira, Marilia de Albuquerque. "Synthesis of nanoparticles the base of polysaccharide Anadenathera macrocarpa (Angico) how to matrix merger of drugs." Universidade Federal do CearÃ, 2010. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=5325.

Full text
Abstract:
Conselho Nacional de Desenvolvimento CientÃfico e TecnolÃgico<br>Polysaccharide nanoparticles obtained from Anadenanthera macrocarpa tree exudates (angico gum, AG) and chitosan (CH) were produced by polyelectrolyte complex formation as well as by graft polymerization of acrylic acid onto a AG backbone. The polyelectrolyte complexes (PECs) were obtained by using AG and its carboxymethylated derivatives with degrees of substitution 0.20 and 0.63 as polianions. Reaction parameters investigated were polymer concentration, molar mass, order of solution addition, charge ratio (n+/n-) and AG degree o
APA, Harvard, Vancouver, ISO, and other styles
4

Hecq, Jérôme. "Development, characterization and evaluation of crystalline nanoparticles for enhancing the solubility, the dissolution rate and the oral bioavailability of poorly water-soluble drugs." Doctoral thesis, Universite Libre de Bruxelles, 2006. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/210816.

Full text
Abstract:
When considering oral administration, drug release from its pharmaceutical form and its dissolution into gastrointestinal fluids generally precedes absorption and systemic availability. The solubility-dissolution behaviour of a drug is frequently the rate-limiting step to absorption of drugs from the gastrointestinal tract (BCS class II drugs). Poor aqueous solubility has always been a very challenging obstacle as it is, together with membrane permeability, an essential factor in the limitation of a drug’s bioavailability following oral administration. Since an increasing number of newly devel
APA, Harvard, Vancouver, ISO, and other styles
5

Pekcagliyan, Gonul. "Synthesis Of Topoisomerase Inhibitor Type Anticancer Drugs Linked Gold Nanoparticles." Master's thesis, METU, 2008. http://etd.lib.metu.edu.tr/upload/3/12609270/index.pdf.

Full text
Abstract:
This study presents studies on camptothecin (CPT), a potent antitumor agent in order to improve its stability and solubility without reducing its activity. The work describes the modification of camptothecin at 20-OH position a new strategy to overcome the stability and solubility problems of the free drug. Camptothecin is conneted to linker that could be processed to a terminal thiol group and this thiol group was connected to gold surface, to obtain CPT-gold nanoparticles. In the first part of the study<br>undecenol was chosen as the starting material and reacted with azobisisobutylonitrile
APA, Harvard, Vancouver, ISO, and other styles
6

Basu, Sarkar Arindam Kochak Gregory Michael. "Carbohydrate nanoparticles a novel drug delivery platform for the systemic route /." Auburn, Ala., 2006. http://repo.lib.auburn.edu/2006%20Summer/Dissertations/BASU_SARKAR_26.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dondero, Russell A. "Silica coating of spinel ferrite nanoparticles." Thesis, Georgia Institute of Technology, 2000. http://hdl.handle.net/1853/27375.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Soundararajan, R. "Enhancing the bioavailability of BCS Class IV drugs using polymeric nanoparticles." Thesis, University College London (University of London), 2016. http://discovery.ucl.ac.uk/1479729/.

Full text
Abstract:
Hydrophobic drugs that are P-gp substrates (BCS Class IV) such as paclitaxel, CUDC-101 etc. pose a serious challenge for oral drug delivery. Polymeric amphiphiles such as N-palmitoyl-N-monomethyl-N,N-dimethyl-N,N,N-trimethyl-6-O-glycolchitosan (GCPQ) are capable of enhancing the bioavailability of hydrophobic drugs by forming nanoparticles. The general hypothesis is that the physicochemical properties of the polymer will affect the colloidal stability, encapsulation efficiency and absorption of hydrophobic drugs. The main aims of the project are as follows: a) to examine the feasibility of usi
APA, Harvard, Vancouver, ISO, and other styles
9

Agostoni, Valentina. "Cyclodextrin-modified metal-organic framework nanoparticles for the efficient delivery of hydrophilic antiviral and anticancer drugs." Thesis, Paris 11, 2013. http://www.theses.fr/2013PA114814.

Full text
Abstract:
Les nanoMOFs – nanoparticles poreuses hybrides ont récemment été introduites dans le domaine de la vectorisation des médicaments afin de combiner les avantages de systèmes purement organiques ou inorganiques. Les nanoMOFs biodégradables et biocompatibles à base de trimesate de fer (MIL-100) ont été étudiées. Une méthode de synthèse «verte» a été développée et validée, ouvrant la voie à la production à grande échelle et à l’utilisation de ces matériaux pour des applications biologiques. Par la suite, les MIL-100 nanoMOFs ont été proposées comme potentiels vecteurs pour l’administration de médic
APA, Harvard, Vancouver, ISO, and other styles
10

Mainardes, Rubiana Mara. "Desenvolvimento de nanopartículas de PLA e PLA-PEG para administração intranasal de zidovudina /." Araraquara : [s.n.], 2007. http://hdl.handle.net/11449/102462.

Full text
Abstract:
Orientador: Maria Palmira Daflon Gremião<br>Banca: Raul Cesar Evangelista<br>Banca: Leila Aparecida Chiavacci<br>Banca: Célio Lopes Silva<br>Banca: Marco Vinícius Chaud<br>Resumo: A zidovudina (AZT) é um fármaco amplamente usado no tratamento da síndrome da imunodeficiência adquirida. O AZT apresenta baixa biodisponibilidade oral pois sofre rápido e extenso metabolismo de primeira passagem hepática, além de curto t1/2. Sendo assim, altas e freqüentes doses são requeridas para se manter concentrações plasmáticas efetivas e, dessa maneira, apresenta graves efeitos colaterais, dose-dependentes, q
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Drugs Nanoparticles"

1

Muttil, Pavan, and Nitesh K. Kunda, eds. Mucosal Delivery of Drugs and Biologics in Nanoparticles. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-35910-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Eerikäinen, Hannele. Preparation of nanoparticles consisting of methacrylic polymers and drugs by an aerosol flow reactor method. VTT Technical Research Centre of Finland, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Müller, Rainer H. Colloidal carriers for controlled drug delivery and targeting: Modification, characterization, and in vivo distribution. Wissenschaftliche Verlagsgesellschaft, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Müller, Rainer H. Colloidal carriers for controlled drug delivery and targeting. CRC Press, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Joshy, K. S., Sabu Thomas, and Vijay Kumar Thakur, eds. Nanoparticles for Drug Delivery. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-2119-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Svenson, Sonke, and Robert K. Prud'homme, eds. Multifunctional Nanoparticles for Drug Delivery Applications. Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-2305-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Y, Aboul-Enein Hassan, ed. Nano chromatography and nano capillary electrophoresis: Pharmaceutical and environmental analyses. John Wiley & Sons, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

McNeil, Scott E. Characterization of nanoparticles intended for drug delivery. Humana Press/Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

McNeil, Scott E., ed. Characterization of Nanoparticles Intended for Drug Delivery. Humana Press, 2011. http://dx.doi.org/10.1007/978-1-60327-198-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

McNeil, Scott E., ed. Characterization of Nanoparticles Intended for Drug Delivery. Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-7352-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Drugs Nanoparticles"

1

Couvreur, P., V. Lenaerts, A. Ibrahim, et al. "Targetable Nanoparticles." In Targeting of Drugs With Synthetic Systems. Springer US, 1986. http://dx.doi.org/10.1007/978-1-4684-5185-6_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Zandanel, Christelle, and Christine Charrueau. "Associating Drugs with Polymer Nanoparticles: A Challenge." In Polymer Nanoparticles for Nanomedicines. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-41421-8_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Joseph, Sonja, and Heike Bunjes. "Solid Lipid Nanoparticles for Drug Delivery." In Drug Delivery Strategies for Poorly Water-Soluble Drugs. John Wiley & Sons Ltd, 2013. http://dx.doi.org/10.1002/9781118444726.ch4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Balland, Olivier, Tula Saison-Behmoaras, Thérèse Garestier, and Claude Hélène. "Nanoparticles as Carriers for Antisense Oligonucleotides." In Targeting of Drugs 5. Springer US, 1996. http://dx.doi.org/10.1007/978-1-4615-6405-8_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ortiz, Andrea C., and Javier O. Morales. "Buccal Delivery of Nanoparticles." In Mucosal Delivery of Drugs and Biologics in Nanoparticles. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-35910-2_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Couvreur, P., and F. Puisieux. "Nanoparticles for the Delivery of Peptides and Proteins." In Targeting of Drugs 4. Springer US, 1994. http://dx.doi.org/10.1007/978-1-4899-1207-7_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Breton, P., D. Roy, L. Marchal-Heussler, C. Seguin, P. Couvreur, and F. Lescure. "New Poly(Methylidene Malonate 2.1.2) Nanoparticles: Recent Developments." In Targeting of Drugs 4. Springer US, 1994. http://dx.doi.org/10.1007/978-1-4899-1207-7_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Häussermann, S., G. Scheuch, and R. Siekmeier. "Targeting Drugs to the Lungs – The Example of Insulin." In Nanoparticles in medicine and environment. Springer Netherlands, 2009. http://dx.doi.org/10.1007/978-90-481-2632-3_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mertz, Damien, and Sylvie Bégin-Colin. "Encapsulation and Release of Drugs from Magnetic Silica Nanocomposites." In Clinical Applications of Magnetic Nanoparticles. CRC Press, 2018. http://dx.doi.org/10.1201/9781315168258-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kreuter, Jörg. "Coating of Nanoparticles with Surfactants: Targeting versus Prolonged Circulation." In Targeting of Drugs 6. Springer US, 1998. http://dx.doi.org/10.1007/978-1-4899-0127-9_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Drugs Nanoparticles"

1

Karnik, Rohit, Frank X. Gu, Suman Bose, et al. "Microfluidic Synthesis of Polymeric Nanoparticles." In ASME 2008 6th International Conference on Nanochannels, Microchannels, and Minichannels. ASMEDC, 2008. http://dx.doi.org/10.1115/icnmm2008-62218.

Full text
Abstract:
A central challenge in the development of drug-encapsulated polymeric nanoparticles is the inability to control the nanoparticle physicochemical properties that affect their biodistribution, drug release, and efficacy. Nanoparticles may be developed by mixing and nanoprecipitation of polymers and drugs dissolved in organic solvents with non-solvents. Inadequate control over this mixing process is a source of variability in the synthesis of these nanoparticles by nanoprecipitation. We demonstrate that rapid and tunable mixing through hydrodynamic flow focusing in a microfluidic device can be us
APA, Harvard, Vancouver, ISO, and other styles
2

Yu, Miao, Vladimir Muzykantov, and Alisa Morss Clyne. "Iron Oxide Nanoparticles Are Less Toxic to Endothelial Cells When Coated With Dextran and Polyethylene Glycol." In ASME 2011 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2011. http://dx.doi.org/10.1115/sbc2011-53702.

Full text
Abstract:
Iron oxide nanoparticles are of particular interest for drug delivery applications, since they can be targeted to a specific location using a magnetic field. We are interested in delivering drugs to atherosclerotic plaques via these nanoparticles. However, prior to using nanoparticles in vivo, they must be shown as relatively non-toxic to cells. We and others have shown that bare iron oxide nanoparticles are readily taken up by cells, where they catalyze production of highly toxic reactive oxygen species [1]. This oxidative stress disrupts the cell cytoskeleton, alters cell mechanics, and may
APA, Harvard, Vancouver, ISO, and other styles
3

Jayasuriya, A. Champa, Anthony Darr, and Nabil A. Ebraheim. "Chemotherapy Drug Encapsulated Poly(Lactic-Co-Glycolic Acid) Nanoparticles." In ASME 2006 International Mechanical Engineering Congress and Exposition. ASMEDC, 2006. http://dx.doi.org/10.1115/imece2006-14694.

Full text
Abstract:
In order to exhibit pharmacological activity at the bone cancer site, high-dose chemotherapy drugs need to be used. This often causes toxicity and unfavorable systemic adverse effects leading to significant problems to the patient. Since nanoparticles are in subcellular size, they can effectively entered to the cell membrane that could result in higher cellular uptake. In this study, we report preparation and characterization of poly(lactic-co-glycolic acid) - PLGA nanoparticles, which encapsulated with chemotherapy drug cisplatin.
APA, Harvard, Vancouver, ISO, and other styles
4

Lueshen, Eric, Indu Venugopal, and Andreas Linninger. "Intrathecal Magnetic Drug Targeting: A New Approach to Treating Diseases of the Central Nervous System." In ASME 2013 2nd Global Congress on NanoEngineering for Medicine and Biology. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/nemb2013-93117.

Full text
Abstract:
Intrathecal (IT) drug delivery is a standard technique which involves direct injection of drugs into the cerebrospinal fluid (CSF)-filled space within the spinal canal to treat many diseases of the central nervous system. Currently, in order to reach the therapeutic drug concentration at certain locations within the spinal canal, high drug doses are used. With no method to deliver the large drug doses locally, current IT drug delivery treatments are hindered with wide drug distributions throughout the central nervous system (CNS) which cause harmful side effects. In order to overcome the curre
APA, Harvard, Vancouver, ISO, and other styles
5

Vakula, Arthur, Ekaterina Bereznyak, Natalia Gladkovskaya, Evgen Dukhopelnikov, Anastasiia Herus, and Sergey Tarapov. "Spectral investigation of magnetite nanoparticles interaction with charged drugs." In 2016 9th International Kharkiv Symposium on Physics and Engineering of Microwaves, Millimeter and Submillimeter Waves (MSMW). IEEE, 2016. http://dx.doi.org/10.1109/msmw.2016.7538006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Grancharova, Tsenka, Stanislava Simeonova, Bissera Pilicheva, and Plamen Zagorchev. "Synergistic effect of magnetic nanoparticles and chemotherapeutic drugs in cancer." In III. Symposium of Young Researchers on Pharmaceutical Technology,Biotechnology and Regulatory Science. Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 2021. http://dx.doi.org/10.14232/syrptbrs.2021.op20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wang, Xiaoliang, Hongchen Gu, and Xinyuan Zhu. "A Novel Remote Controllable Drug Delivery System Triggered by Heating From Magnetic Nanoparticles." In ASME 2009 Second International Conference on Micro/Nanoscale Heat and Mass Transfer. ASMEDC, 2009. http://dx.doi.org/10.1115/mnhmt2009-18052.

Full text
Abstract:
Target drug delivery is one of the core issues in modern medicine. Although both thermo-sensitive and magnetic drug vehicles have been developed for this purpose, reliable drug targeting is yet to achieve, because it’s hard to control local temperature in body for thermo-sensitive drugs, and it’s also difficult to control the colloidal sizes of magnetic vehicles to meet the requirements for both long-time circulation and magnetic responsibility. Here we present a new technology to solve these two problems. The drug (taxel) was combined with hyper-branched thermo-sensitive polymer and magnetic
APA, Harvard, Vancouver, ISO, and other styles
8

Ditto, Andrew J., Nikki K. Robbishaw, Matthew J. Panzner, Wiley J. Youngs, and Yang H. Yun. "Targeting Ovarian Cancer Cells With Rapidly Biodegradable L-Tyrosine Polyphosphate Nanoparticles Decorated With Folate." In ASME 2011 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2011. http://dx.doi.org/10.1115/sbc2011-53138.

Full text
Abstract:
Chemotherapy employs toxic chemicals to kill rapidly dividing cells. Examples of FDA approved antineoplastic drugs include cisplatin, doxorubicin, and paclitaxel. Since most of these drugs are nonspecific, they also damage normal tissues as well as the aberrant tumors. As a result, non-specific therapies have multiple side effects, which include myelosuppression, mucositis, alopecia, nephrotoxicity, and genotoxcity. In order to minimize these issues, researchers have begun to conjugate antineoplastic chemicals with targeting moieties or encapsulate drugs into nanoparticles decorated with compo
APA, Harvard, Vancouver, ISO, and other styles
9

Pereira, Rosa, Tommy Julianto, Kah Yuen, and Abu Abdul Majeed. "Anionic Eudragit nanoparticles as carriers for oral administration of peptidomimetic drugs." In 2006 International Conference on Nanoscience and Nanotechnology. IEEE, 2006. http://dx.doi.org/10.1109/iconn.2006.340611.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Qian, Jun, Arash Gharibi, Xin Li, and Sailing He. "Organically Modified Silica Nanoparticles with Photosensitizing Drugs Encapsulated for Photodynamic Therapy." In Asia Optical Fiber Communication and Optoelectronic Exposition and Conference. OSA, 2008. http://dx.doi.org/10.1364/aoe.2008.sun4.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Drugs Nanoparticles"

1

Atif Syed, Atif Syed. Targeted Drug Delivery by using Magnetic Nanoparticles. Experiment, 2013. http://dx.doi.org/10.18258/0788.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Basu, Sayani. Nanoparticle-Based Therapeutics for the Treatment of Stroke. Nature Library Ltd, 2020. http://dx.doi.org/10.47496/nl.blog.13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Jo, Seongbong, Han-Joung Cho, Jung-Eun Base, and Vivek K. Garripelli. Hypoxia-sensitive, Multifunctional Nanoparticles for Targeted Drug Delivery to Breast Cancer. Defense Technical Information Center, 2012. http://dx.doi.org/10.21236/ada567915.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Band, Hamid, Srikumar Raja, and Tatiana Bronich. Mechanism-Based Enhanced Delivery of Drug-Loaded Targeted Nanoparticles for Breast Cancer Therapy. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada577110.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Band, Hamid, and Tatiana Bronich. Mechanism-Based Enhanced Delivery of Drug-Loaded Targeted Nanoparticles for Breast Cancer Therapy. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada599969.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bronich, Tatiana, and Hamid Band. Mechanism-Based Enhanced Delivery of Drug-Loaded Targeted Nanoparticles for Breast Cancer Therapy. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada600027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bronich, Tatiana, Hamid Band, and Srikumar Raja. Mechanism-Based Enhanced Delivery of Drug-Loaded Targeted Nanoparticles for Breast Cancer Therapy. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada580965.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Sledge, George W. Nanoparticle: Monoclonal Antibody Conjugates: A Novel Drug Delivery System in Human Breast Cancer. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada420569.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sledge, George. Nanoparticle: Monoclonal Antibody Conjugates: A Novel Drug Delivery System in Human Breast Cancer. Defense Technical Information Center, 2000. http://dx.doi.org/10.21236/ada393348.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Wang, Paul C. A Partnership Training Program: Studying Targeted Drug Delivery Using Nanoparticles in Breast Cancer Diagnosis and Therapy. Defense Technical Information Center, 2012. http://dx.doi.org/10.21236/ada568802.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Drugs Nanoparticles' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography